Subtype 1 demonstrated increased MIND strength with multi‐neurotransmitter system alterations and associations with multiple MDD‐related genes (SST and CUX2), while subtype 2 exhibited reduced MIND strength linked to glutamatergic dysfunction and selective MDD‐related gene involvement (CRH). This evidence concerns the gene CUX2 and major depressive disorder.